Zhejiang Tailin Medical Engineering Co., Ltd. announced that it will raise CNY 170,000,000 in an equity round of funding on December 12, 2023. The transaction will include participation from returning investor Zhejiang Tailin BioEngineering Co.,Ltd. The transaction has been approved by the 21st Meeting of the Company?s 3rd Directorate. After the transaction, Zhejiang Tailin Medical Engineering Co., Ltd.'s registered capital will increase from CNY 50,000,000 to CNY 100,000,000.
Zhejiang Tailin BioEngineering Co.,Ltd
Equities
300813
CNE100003S89
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.94 CNY | -12.95% | +28.43% | -2.37% |
1st Jan change | Capi. | |
---|---|---|
-2.37% | 413M | |
+12.06% | 225B | |
+12.07% | 186B | |
+13.88% | 135B | |
+27.12% | 107B | |
+0.91% | 63.56B | |
+6.74% | 51.32B | |
+13.39% | 51.04B | |
+8.81% | 43.3B | |
+4.14% | 36.99B |
- Stock Market
- Equities
- 300813 Stock
- News Zhejiang Tailin BioEngineering Co.,Ltd
- Zhejiang Tailin Medical Engineering Co., Ltd. announced that it expects to receive CNY 170 million in funding from Zhejiang Tailin BioEngineering Co.,Ltd